Wall Street’s top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly.

Top 5 Upgrades:

• Loop Capital upgraded Qualcomm (QCOM) to Buy from Hold with an $185 price target. Year-to-date share price underperformance has been “fueled by a perfect storm of circumstances,” but memory chips won’t remain in short supply forever and the smartphone market should recover and normalize from the initial shock, the firm tells investors. Wells Fargo also upgraded Qualcomm but to Equal Weight from Underweight with a price target of $150, up from $135.

• Morgan Stanley upgraded Booking Holdings (BKNG) to Overweight from Equal Weight with a price target of $5,500, down from $6,150. Even as agentic tools evolve, the firm sees Booking staying “a key driver of travel,” contending that the company will still “own the customer,” capture “robust” traveler data and use those to drive high margin direct business.

• JPMorgan upgraded Domino’s Pizza (DPZ) to Overweight from Neutral with a price target of $450, down from $460. The firm says the company’s “steady share-taking” business model screens attractive to buy the shares at the $400 level.

• Seaport Research upgraded Fox Corp. (FOXA) to Buy from Neutral with a $64 price target. The firm views the recent pullback in the shares as overdone.

• Raymond James double upgraded Genuine Parts (GPC) to Strong Buy from Market Perform with a $145 price target. The firm now sees a “constructively asymmetric” setup for the shares based on “conservative sum-of-the-parts math.”

Top 5 Downgrades:

• BTIG downgraded Hims & Hers (HIMS) to Neutral from Buy with no price target following the company’s “disappointing” Q4 results. The firm, which also notes “weak” Q1 guidance, slowing revenue growth, and increased legal and regulatory risk, says its “primary concern” is that even though Hims & Hers stated that there will be about a $65M revenue headwind in Q1 due to 503A “shipping cadences,” this may at least in part be due to increased regulatory scrutiny, possible changes in marketing and advertising, or greater demand for branded GLP-1s from consumers.

• BNP Paribas downgraded Comcast (CMCSA) to Underperform from Neutral with a price target of $27, down from $28. Comcast looks “most exposed” to incremental fiber headwinds, says the firm.

• BNP Paribas downgraded Cable One (CABO) to Underperform from Neutral with a price target of $80, down from $125 ahead of the earnings report on February 26. The firm is “incrementally more bearish” on cable.

• Barclays double downgraded Gossamer Bio (GOSS) to Underweight from Overweight with a price target of 30c, down from $9. The company’s Phase 3 pulmonary arterial hypertension highlights the challenges of drug development, the firm tells investors in a research note. Leerink and Wedbush also downgraded Gossamer Bio but to Neutral-equivalent ratings following “disappointing” Phase 3 PROSERA results.

• UBS downgraded Arcellx (ACLX) to Neutral from Buy with a price target of $115, up from $110, citing Gilead’s (GILD) acquisition of Arcellx for of $7.8B or $115 per share. The acquisition makes sense, the firm tells investors in a research note.